Important! If you do the following survey, please tell them Annemarie DellaGuardia referred you. As stated below, I will weceive a referral bonus, and you will to if you refer people. It took about a half hour and they were very friendly.

I thought you might be interested in this opportunity. My name is David Mechlin and my company is Video Chat Network (https://videochatnetwork.net/).

We are an independent research firm engaged in a project for a pharmaceutical marketing firm who works with manufacturers who are highly interested how their patients understand and use their treatments for best results.

We would like to speak with adult patients or the caregivers of children with Type I Gaucher disease who currently taking enzyme replacement therapy (ERT). They may be taking either Cerezyme, Elelyso, Vpriv or Cerdelga (US only).

The purpose of the project is to learn more about the opinions and points of view of patients on living with Gaucher disease about current treatment options, to better address the overall treatment and lives of Gaucher disease patients everywhere.

If you are a patient or caregiver meeting these criteria and are interested participating in a 60-minute online video chat interview in your own home, we will compensate you $150 for your time and opinions. If you can refer us someone qualified, we will compensate you $50 for every interview performed that your referral provides.

All you will need is access to a strong internet connection along with a device with a camera and microphone such as a computer, a tablet, or smartphone. Times are currently available for interviews early the week of June 20th.

Please know we have extensive experience conducting health care/pharmaceutical research which you can check out on our site (http://videochatnetwork.net/pharma-redo/). We are always respectful of patients and their condition.


Please send me an email or call me at 646-772-7016 if you are interested in helping us out.

Thank you for your interest and help.

David Mechlin
Video Chat Network
This email address is being protected from spambots. You need JavaScript enabled to view it.
(M) 646-772-7016

Due to the high costs of maintaining the site, we are not currently accepting new users. We apologize for the inconvenience. Thank you for your support.

We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.